Supplementary Table 1.
Study quality assessment of included studies
| Study | Selection | Comparability Factors comparable between the groups |
Outcome | Score Maximum=8 | Quality High >6, medium 4-6, low ≤3 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||||
| Representativeness of the average adult in community | Cohort size | Information on clinical outcomes | Outcome not present at start | Adequate clinical assessment | Follow-up time | Adequacy of follow-up | ||||
| Pai et al., 2015 | 0.5 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | Medium |
| Lakhtakia et al., 2016 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | Medium |
| Choi et al., 2018 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | Medium |
| De La Sena et al., 2018 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | Medium |
| Thosani et al., 2018 | 0.5 | 0.5 | 1 | 1 | 1 | 1 | 1 | 0.5 | 6.5 | High |
| Fathima et al., 2019 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | Medium |
| De Nucci et al., 2019 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | Medium |
| Oleinikov et al., 2019 | 0.5 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | Medium |
| Dancour et al., 2019 | 0.5 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | Medium |
| Barthet et al., 2019 | 0.5 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | Medium |
| Trosic-Ivanisevic et al., 2019 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | Medium |
| Younis et al., 2019 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | Medium |
| Malikowski et al., 2020 | 0.5 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 6.5 | High |
| Levy et al., 2012 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | Medium |
| Park et al., 2015 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0.5 | 5.5 | Medium |
| Yang et al., 2015 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | Medium |
| Qin et al., 2016 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | Medium |
| Paik et al., 2016 | 0.5 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 6.5 | Medium |
| Choi et al., 2018 | 0 | 0.5 | 1 | 1 | 1 | 1 | 1 | 1 | 6.5 | High |
| Matsumoto et al., 2020 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | Medium |